Jain Global’s ResMed RMD Stock Holding History

Jain Global’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$771K	Buy	3,956 +118	+3%	+$24.5K	﹤0.01%	1061
2026 Q1	$862K	Buy	+3,838	New	+$956K	﹤0.01%	833
2025 Q3	–	Sell	-4,671	Closed	-$1.21M	–	1427
2025 Q2	$1.21M	Buy	+4,671	New	+$1.11M	0.01%	612
2025 Q1	–	Sell	-17,841	Closed	-$4.08M	–	1304
2024 Q4	$4.08M	Buy	+17,841	New	+$4.3M	0.12%	156

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jain Global's RMD Position: Q2 2026 in Review

Jain Global increased its ResMed (RMD) stake by 3.1% in Q2 2026, buying an estimated $24.5K and bringing the position to 3,956 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Jain Global first reported a position in RMD in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.08M in Q4 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Jain Global held 3,956 shares of ResMed worth $771K as of Q2 2026.
Jain Global bought 118 ResMed shares in Q2 2026, an estimated $24.5K.
ResMed made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1061 holding.
Jain Global first reported a position in ResMed in Q4 2024 and has held it in 4 quarters since.
Jain Global's ResMed position peaked at $4.08M in Q4 2024.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.